Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers
NCT00709514Phase 2Completed
- Sponsor
- Oneness Biotech Co., Ltd.
- Start
- Dec 2008
- Primary completion
- Apr 2011
- Modality
- Botanical drug
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing DCB-WH1 Ointment with Placebo (2 arms). Primary endpoint: Incidence of complete ulcer closure at 12 weeks. Started Dec 2008; status: completed.
02
Drugs
Fespixon
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00709514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709514.